Preston Klassen
2009 - Orexigen Therapeutics
In 2009, Preston Klassen earned a total compensation of $1.2M as Head of Global Contrave Program and Senior Vice President, Product Development at Orexigen Therapeutics.
Compensation breakdown
| Bonus | $35,000 |
|---|---|
| Option Awards | $875,600 |
| Salary | $38,333 |
| Other | $225,020 |
| Total | $1,173,953 |
Klassen received $875.6K in option awards, accounting for 75% of the total pay in 2009.
Klassen also received $35K in bonus, $38.3K in salary and $225K in other compensation.
Rankings
In 2009, Preston Klassen's compensation ranked 3,911th out of 9,885 executives tracked by ExecPay. In other words, Klassen earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,911 out of 9,885 | 60th |
Division Manufacturing | 1,387 out of 3,690 | 62nd |
Major group Chemicals And Allied Products | 263 out of 866 | 70th |
Industry group Drugs | 153 out of 638 | 76th |
Industry Pharmaceutical Preparations | 120 out of 446 | 73rd |
Source: SEC filing on April 27, 2012.
Klassen's colleagues
We found seven more compensation records of executives who worked with Preston Klassen at Orexigen Therapeutics in 2009.
2009
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2009
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2009
Dawn Viveash
Orexigen Therapeutics
Senior Vice President, Regulatory Affairs
2009
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
2009
Joseph Hagan
Orexigen Therapeutics
Chief Business Officer
2009
Heather Turner
Orexigen Therapeutics
General Counsel
2009
Eckard Weber
Orexigen Therapeutics